meta-iodobenzylguanidine (i-131) injection for therapeutic use
ge healthcare pte. ltd. - meta-iodobenzylguanidine (i-131) - injection - 185-740 mbq/ml - meta-iodobenzylguanidine (i-131) 0.185 - 0.740 gbq/ml
[¹³¹i] meta-iodobenzylguanidine for diagnostic use
ge healthcare limited - iobenguane - solution for injection - iobenguane - diagnostic radiopharmaceuticals
sodium iodide [i-131] injection 74 mbqml
ge healthcare pte. ltd. - sodium iodide [i-131] - injection - 74 mbq/ml - sodium iodide [i-131] 74 mbq/ml
sodium iodide [i-131] injection 925 mbqml
ge healthcare pte. ltd. - sodium iodide [i-131] - injection - 925 mbq/ml - sodium iodide [i-131] 925 mbq/ml
ge healthcare
ge international inc, tanzania - corometrics 170 series,corometrics 250 series fetal monitors -
datscan
ge healthcare b.v. - ioflupane (123l) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. datscan is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
sehcat 370kbq capsules
ge healthcare limited - tauroselcholic acid - capsule, hard - 370 k.bequerel - other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals; selenium (75se) tauroselcholic acid
amersham indium (111in) chloride 185mbq/0.5ml injection
ge healthcare australia pty ltd - indium (111in) chloride, quantity: 370 mbq/ml - injection, solution - excipient ingredients: hydrochloric acid - for the radiolabelling of approved polyaminocarboxylic acid derivatised monoclonal antibody preparations for in vivo diagnostic imaging procedures.
amersham indium (111in) chloride 74mbq/0.2ml injection
ge healthcare australia pty ltd - indium (111in) chloride, quantity: 370 mbq/ml - injection, solution - excipient ingredients: hydrochloric acid - for the radiolabelling of approved polyaminocarboxylic acid derivatised monoclonal antibody preparations for in vivo diagnostic imaging procedures.
sodium chromate (cr51) solution bp injection
ge healthcare australia pty ltd - sodium chromate(51cr) -